+

WO2000066769A3 - Systeme et technique permettant d'examiner un carcinome du nasopharinx - Google Patents

Systeme et technique permettant d'examiner un carcinome du nasopharinx Download PDF

Info

Publication number
WO2000066769A3
WO2000066769A3 PCT/CA2000/000456 CA0000456W WO0066769A3 WO 2000066769 A3 WO2000066769 A3 WO 2000066769A3 CA 0000456 W CA0000456 W CA 0000456W WO 0066769 A3 WO0066769 A3 WO 0066769A3
Authority
WO
WIPO (PCT)
Prior art keywords
screening
nasopharyngeal carcinoma
disclosed
methods
dna
Prior art date
Application number
PCT/CA2000/000456
Other languages
English (en)
Other versions
WO2000066769A2 (fr
Inventor
Raymond H W Ng
Victor Daykin
John Phillips
Original Assignee
Advance Sentry Corp
Raymond H W Ng
Victor Daykin
John Phillips
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Sentry Corp, Raymond H W Ng, Victor Daykin, John Phillips filed Critical Advance Sentry Corp
Priority to AU42795/00A priority Critical patent/AU4279500A/en
Priority to EP00922366A priority patent/EP1173615A2/fr
Priority to CA002370108A priority patent/CA2370108A1/fr
Publication of WO2000066769A2 publication Critical patent/WO2000066769A2/fr
Publication of WO2000066769A3 publication Critical patent/WO2000066769A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des techniques permettant d'examiner et de diagnostiquer un carcinome du nasopharinx. Cette invention concerne aussi des amorces d'ADN et des sondes d'ADN qui conviennent pour ces techniques.
PCT/CA2000/000456 1999-04-30 2000-04-28 Systeme et technique permettant d'examiner un carcinome du nasopharinx WO2000066769A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU42795/00A AU4279500A (en) 1999-04-30 2000-04-28 System and method for screening of nasopharyngeal carcinoma
EP00922366A EP1173615A2 (fr) 1999-04-30 2000-04-28 Systeme et technique permettant d'examiner un carcinome du nasopharinx
CA002370108A CA2370108A1 (fr) 1999-04-30 2000-04-28 Systeme et technique permettant d'examiner un carcinome du nasopharinx

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13194499P 1999-04-30 1999-04-30
US60/131,944 1999-04-30

Publications (2)

Publication Number Publication Date
WO2000066769A2 WO2000066769A2 (fr) 2000-11-09
WO2000066769A3 true WO2000066769A3 (fr) 2001-10-18

Family

ID=22451713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2000/000456 WO2000066769A2 (fr) 1999-04-30 2000-04-28 Systeme et technique permettant d'examiner un carcinome du nasopharinx

Country Status (5)

Country Link
EP (1) EP1173615A2 (fr)
CN (1) CN1367844A (fr)
AU (1) AU4279500A (fr)
CA (1) CA2370108A1 (fr)
WO (1) WO2000066769A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1616012T3 (da) 2003-04-24 2008-04-21 San Raffaele Centro Fond Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser deraf
SG11201602140VA (en) * 2013-10-04 2016-04-28 Advance Sentry Corp Methods and devices for nasopharyngeal carcinoma screening

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007882A1 (fr) * 1991-10-25 1993-04-29 Isis Pharmaceuticals, Inc. Compositions et procedes concernant le traitement de maladies dues au virus d'epstein-barr
DE19627932A1 (de) * 1996-07-11 1998-01-15 Boehringer Mannheim Gmbh Sensitiver Epstein-Barr-Virus DNA-Nachweis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007882A1 (fr) * 1991-10-25 1993-04-29 Isis Pharmaceuticals, Inc. Compositions et procedes concernant le traitement de maladies dues au virus d'epstein-barr
DE19627932A1 (de) * 1996-07-11 1998-01-15 Boehringer Mannheim Gmbh Sensitiver Epstein-Barr-Virus DNA-Nachweis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRINK A ET AL: "Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr Virus latent transcripts, and its comparison with reverse transcriptase PCR", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 36, November 1998 (1998-11-01), pages 3164 - 69, XP000979423 *
LO Y ET AL: "Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma", CANCER RESEARCH, vol. 59, 15 March 1999 (1999-03-15), pages 1188 - 91, XP000979273 *
SHEEN T-S ET AL: "Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a goog supplement to the serological screening method", HEAD AND NECK, vol. 20, December 1998 (1998-12-01), pages 732 - 38, XP000979434 *
TSAI S-T ET AL: "Epstein-Barr Virus detection in nasopharyngeal tissues with suspected Nasopharyngeal Carcinoma", CANCER, vol. 82, April 1998 (1998-04-01), pages 1449 - 53, XP000979422 *

Also Published As

Publication number Publication date
CA2370108A1 (fr) 2000-11-09
CN1367844A (zh) 2002-09-04
EP1173615A2 (fr) 2002-01-23
AU4279500A (en) 2000-11-17
WO2000066769A2 (fr) 2000-11-09

Similar Documents

Publication Publication Date Title
AU2001283916A1 (en) Method and nucleic acids for the analysis of astrocytomas
AU2922497A (en) Detection probes, kits and assays
AU4700699A (en) Nucleotide detection method
AU4487297A (en) System, apparatus and method for the detection and removal of viruses in macros
AU2730597A (en) Method for simultaneous detection of multiple fluorophores for (in situ) hybridization
WO2000012726A3 (fr) Heparinases a conception rationnelle derivees de l'heparinase i et ii
AU8724598A (en) System and method for automatically detecting malignant cells and cells having malignancy-associated changes
AU2849800A (en) Methods and apparatus for detecting polynucleotide hybridization
AU3027699A (en) Nucleic acid analysis method
AU6551498A (en) Method, system and apparatus for determining prognosis in atrial fibrillation
AU2000246450A1 (en) Method and device for finding, collecting and acting upon units of information
AU2001243273A1 (en) System and method for diagnosing pathologic heart conditions
AU5931900A (en) Method and apparatus for inducing sputum samples for diagnostic evaluation
EP0685199A3 (fr) Procédé d'analyse d'une enzyme et dispositif pour sa mise en oeuvre.
AU4253497A (en) Dyes designed for high sensitivity detection of double-stranded dna
AU1739097A (en) Enzyme detection/assay method and substrates
AU2747597A (en) Method, compositions and kit for detection and identification of microorganisms
AU3347500A (en) Methods and kits for characterizing gc-rich nucleic acid sequences
AU2637299A (en) Method and kit for the detection of explosives
AU2735797A (en) Detection probes, kits and assays
AU3516899A (en) Method and probes for the detection of chromosome aberrations
AU5594200A (en) Microsystems integrated testing and characterization system and method
GB9913051D0 (en) Method and apparatus for enzyme detection
WO2001009384A3 (fr) Analyse en serie d'alterations genetiques
AU4896899A (en) Method and device for photolithographic production of dna, pna and protein chips

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00808453.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2370108

Country of ref document: CA

Ref document number: 2370108

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000922366

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000922366

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000922366

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载